" /> Breast Cancer Type 1 Susceptibility Protein - CISMeF





Preferred Label : Breast Cancer Type 1 Susceptibility Protein;

NCIt synonyms : Breast-Ovarian Cancer Protein; RING Finger Protein 53; Breast Cancer 1, Early Onset Protein; BRCA1; BRCA1 Protein; EC 2.3.2.27; Fanconi Anemia, Complementation Group S; Breast and Ovarian Cancer Susceptibility Protein 1; Protein Phosphatase 1, Regulatory Subunit 53; BRCA1/BRCA2-Containing Complex, Subunit 1; EC 6.3.2.-, Formerly; RING-Type E3 Ubiquitin Transferase BRCA1;

NCIt definition : Breast cancer type 1 susceptibility protein (1863 aa, 208 kDa) is encoded by the human BRCA1 gene. This protein plays a role in both the maintenance of DNA and the mediation of ubiquitin E3 ligase activity.;

NCIt note : Encoded by human BRCA1 Gene (Granin Family) and expressed in proliferating cells, 1863-amino acid 190-220 kD BRCA1 phosphoprotein contains a N-terminal DNA-binding RING finger, nuclear localization signals, an C-terminal acidic domain, and two C-terminal BRCT domains. Phosphorylation peaks in S/M. BRCA1 is involved in cell cycle arrest transcription, DNA repair, and recombination. CTIP/BRCA1/ZBRK1 regulates GADD45 transcription. BRCA1 inhibits ERA transcription and triggers apoptosis through JNK/SAPK. BRCA1 is part of the BASC DNA repair complex and the SWI/SNF complex. BRCA1 may associate with BRCA2, BARD1 (S phase), RNA Polymerase II via RNA helicase A, and RB1, RBBP7, RBBP4, HDAC1, and HDAC2 (via BRCT domain). CHK2 serine phosphorylates BRCA1. BRCA1 mutations occur in breast and ovarian cancers. (fSwiss-Prot, OMIM); BRCA1, which functions as a tumor suppressor in human breast cancer cells, is a nuclear phosphoprotein which associates with RNA polymerase II holoenzyme. Mutations in BRCA1 are predicted to be responsible for approximately 45% of inherited breast cancer and more than 80% of inherited breast and ovarian cancer. BRCA1 may function as a transcriptional regulator, due to an amino terminal DNA-binding ring finger motif, nuclear localization signals, and an acidic carboxy terminal domain. BRCA1 is also a granin-like protein that functions as a secreted growth inhibitory protein. BRCA1 may normally serve as a negative regulator of mammary epithelial cell growth. This function is compromised in breast cancer either by direct mutation or by alterations in gene expression. BRCA1 participates in transcription-coupled repair of oxidative DNA damage. (LocusLink);

Details


You can consult :


Nous contacter.
29/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.